Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
To assess the dominance between hypoinsulinemia and hypoleptinemia as factors in the development of hyperphagia in streptozotocin (STZ)-induced diabetes mellitus (STZ-DM) rodents with respect to hormone-neuropeptide interactions, changes in gene expression of agouti gene-related protein (AGRP) in the arcuate nucleus of the hypothalamus were investigated using STZ-DM rats, fasting Zucker fa/fa rats and STZ-DM agouti (STZ-DM A(y)/a) mice. AGRP mRNA and neuropeptide Y mRNA were both significantly up-regulated in STZ-DM rats, which are associated with body weight loss, hyperglycemia, hypoinsulinemia and hypoleptinemia. We proceeded to analyze whether insulin or leptin played the greater role in the regulation of AGRP using Zucker fa/fa rats. The AGRP mRNA did not differ significantly between fasted fa/fa rats, which have both leptin-insensitivity and hypoinsulinemia, and fed Zuckers, which have leptin-insensitivity and hyperinsulinemia. We further found that up-regulation of AGRP expression was normalized by infusion of leptin into the third cerebroventricle (i3vt), but not by i3vt infusion of insulin, although up-regulation of AGRP was partially corrected by systemic insulin infusion. The latter finding supports hypoleptinemia as a key-modulator of STZ-DM-induced hyperphagia because systemic insulin infusion, at least partially, restored hypoleptinemia through its acceleration of fat deposition, as demonstrated by the partial recovery of lost body weight. After STZ-DM induction, A(y)/a mice whose melanocortin-4 receptor (MC4-R) was blocked by ectopic expression of agouti protein additionally accelerated hyperphagia and up-regulated AGRP mRNA, implying that the mechanism is triggered by a leptin deficit rather than by the main action of the message through MC4-R. Hypoleptinemia, but not hypoinsulinemia per se, thus develops hyperphagia in STZ-DM rodents. These results are very much in line with evidence that hypothalamic neuropeptides are potently regulated by leptin as downstream targets of its actions.
Hidaka
S
S
Department of Internal Medicine I, School of Medicine, Oita Medical University, Oita, Japan.
Yoshimatsu
H
H
Kondou
S
S
Oka
K
K
Tsuruta
Y
Y
Sakino
H
H
Itateyama
E
E
Noguchi
H
H
Himeno
K
K
Okamoto
K
K
Teshima
Y
Y
Okeda
T
T
Sakata
T
T
D054366:Agouti Signaling Protein; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002552:Cerebral Ventricles; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000503:physiopathology*; D005247:Feeding Behavior / Q000187:drug effects; D005508:Food Deprivation; D005786:Gene Expression Regulation; D006963:Hyperphagia / Q000235:genetics / Q000503:physiopathology*; D007031:Hypothalamus / Q000378:metabolism; D007263:Infusions, Parenteral; D007328:Insulin / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology*; D036341:Intercellular Signaling Peptides and Proteins; D020738:Leptin / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology*; D008297:Male; D009478:Neuropeptide Y / Q000235:genetics*; D011498:Protein Precursors / Q000235:genetics; D011506:Proteins / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D011924:Rats, Zucker; D014158:Transcription, Genetic; D015431:Weight Loss
D054366:Agouti Signaling Protein; C515184:Asip protein, rat; D001786:Blood Glucose; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D020738:Leptin; D009478:Neuropeptide Y; D011498:Protein Precursors; D011506:Proteins; D012333:RNA, Messenger; C042084:preproneuropeptide Y